Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Hydrofluoroalkane mandate in effect January 1, 2009: Switch from chlorofluorocarbon- to hydrofluoroalkane-propelled inhalers requires active transition.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Peters S;Peters S
- Source:
Clinical cornerstone [Clin Cornerstone] 2009; Vol. 9 (3), pp. 50-3.
- Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
- Language:
English
- Additional Information
- Source:
Publisher: Excerpta Medica Country of Publication: United States NLM ID: 9816002 Publication Model: Print Cited Medium: Internet ISSN: 1873-4480 (Electronic) Linking ISSN: 18734480 NLM ISO Abbreviation: Clin Cornerstone Subsets: MEDLINE
- Publication Information:
Original Publication: Belle Mead, N.J. : Excerpta Medica, c1998-
- Subject Terms:
- Abstract:
The manufacture, sale, and distribution of chlorofluorocarbon-propelled albuterol metered-dose inhalers ceased as of December 31, 2008. Clinicians should actively transition patients to currently available hydrofluoroalkane-propelled devices, providing concise education and instruction for using the newer devices.
- Accession Number:
0 (Aerosol Propellants)
0 (Chlorofluorocarbons)
0 (Hydrocarbons, Fluorinated)
R40P36GDK6 (apaflurane)
- Publication Date:
Date Created: 20090929 Date Completed: 20091222 Latest Revision: 20191111
- Publication Date:
20240829
- Accession Number:
10.1016/s1098-3597(09)80013-6
- Accession Number:
19781516
No Comments.